Interestingly, these investigators hypothesized that this metabolic phenotype might be an early adaptive response to the eventual progression to T2DM, allowing normoglycemia not only due to the compensatory hyperinsulinemia produced by β-cells, but also by lowering glucagon secretion by α-cells. The gene discussed is GCG; the disease is type 2 diabetes mellitus.